ArticleAME case reports2026
Comprehensive analysis of primary thyroid lymphoma: a case report and review of diagnostic and treatment protocols.
Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In clinical practice, primary thyroid lymphoma (PTL) is a rare malignant neoplasm, making up only 2-5% of all thyroid malignancies. The most common type of PTL is diffuse large B-cell lymphoma (DLBCL), which accounts for about 60-70% of thyroid lymphomas. Typically, patients present with a painless progressive growth of neck masses, accompanied by local compressive symptoms. Currently, accurate diagnosis and treatment selection for PTL are significantly challenging. Research on PTL involving the pyramidal lobe is relatively scarce, resulting in persistently high rates of misdiagnosis and missed diagnosis. Additionally, uncertainties remain regarding the optimal surgical resection range and chemotherapy dosage for such combined lesions. Case Description: Here, we report a case involving a 66-year-old woman with a 16-year history of hypothyroidism, who presented with typical compression symptoms. After surgical resection, the patient was diagnosed with DLBCL of the right thyroid and pyramidal lobe, based on pathology and then underwent rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) chemotherapy. Following treatment, there was no recurrence or metastasis observed during the 6-month follow-up period. Conclusions: This case proves that the incidence of pyramidal lobe lymphoma involvement in PTL is extremely low and prone to missed diagnosis. Perioperatively, we should strengthen the awareness of this issue to reduce the possibility of misdiagnosis and missed diagnosis. Meanwhile, with a clear pathological diagnosis, a reasonable and effective chemotherapy regimen can achieve excellent therapeutic effects. Local symptoms can also be effectively alleviated through surgical resection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.